Zomedica Pharmaceuticals Corp.
100 Phoenix Drive, Suite 180
Ann Arbor, Michigan 48108
May 20, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Zomedica Pharmaceuticals Corp. (the “Company”) | |
Registration Statement on Form S-1, as amended (File No. 333-238322) |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 9:00 a.m., Eastern Time, on May 26, 2020, or as soon as practicable thereafter.
Please call John D. Hogoboom of Lowenstein Sandler LLP at (973) 597-2382 to confirm the effectiveness of the Registration Statement or with any questions.
[Signature page follows.]
U.S. Securities and Exchange Commission
May 20, 2020
Page 2
Very truly yours, | |||
ZOMEDICA PHARMACEUTICALS CORP. | |||
By: | /s/ Shameze Rampertab | ||
Name: | Shameze Rampertab | ||
Title: | Interim Executive Officer and Chief Financial Officer |
- 2 -